LoginCreate an account

  Username: Password:
 
Home

Merck, Schering-Plough in $42M Vytorin settlement

E-mail Print PDF
User Rating: / 0
PoorBest 

NEW YORK (AP) — Drug developers Merck & Co. and Schering-Plough Corp. said Wednesday they will pay $41.5 million to settle a series of lawsuits claiming they delayed key study results on their cholesterol drug Vytorin because the data was unfavorable.

In January 2008, the companies released long-awaited study data showing Vytorin and Zetia were no more effective than Zocor, an older and less expensive cholesterol treatment at reducing plaque buildup in arteries. Zocor is combined with Zetia to make Vytorin.

The companies finished testing Vytorin in 2006 and the drug was given Food and Drug Administration approval based on its ability to lower cholesterol. Merck and Schering-Plough were criticized for not releasing the data earlier. Following the study results, sales of Vytorin sunk.

During the second quarter of 2009, combined sales of Vytorin and Zetia fell 10 percent to $1 billion.

Merck and Schering-Plough did not acknowledge any wrongdoing or liability as part of the settlement, which comes a month after a separate $5.4 million settlement with attorneys general from 35 states and the District of Columbia.

Whitehouse Station, N.J.-based Merck is in the midst of a $41.1 billion buyout of Schering-Plough.

"These agreements will allow the companies to avoid continuing defense costs and remain focused on discovering, developing and delivering novel medicines and vaccines," said Bruce N. Kuhlik, executive vice president and general counsel at Merck.

The company previously disclosed more than 140 lawsuits pending in federal court in New Jersey. The deal actually involves two settlements split with consumers and health plans. The consumer settlements still require court approval.

Charges for the settlement were included in the companies' second-quarter results for the cholesterol drug joint venture.

 

Copyright 2009 The Associated Press.

 

 
The Axe Files with David Axelrod
David Axelrod, the founder and director of the University of Chicago Institute of Politics, brings you The Axe Files, a series of revealing interviews with key figures in the political world. Go beyond the soundbites and get to know some of the most interesting players in politics.
  • Ep. 52 - Katie Couric
    Katie Couric, global anchor for Yahoo News, sits down with David in her New York apartment to discuss her wide-ranging journalism career from 9/11 to “The Today Show” to her 2008 interview with Sarah Palin, her views on the current media landscape, and the 1998 death of her husband Jay after a nine-month battle with colon cancer.
  • Ep. 51 - Samantha Power
    Samantha Power, U.S. Ambassador to the United Nations, chats with David in New York about growing up in Ireland, how she went from a sports reporter at Yale to writing a Pulitzer Prize-winning book on U.S. foreign policy, and her take on the Obama administration's approach to conflicts in Libya, Syria, and elsewhere.

  • Ep. 50 - Michael Nutter
    Michael Nutter, former mayor of Philadelphia, speaks with David about going from nightclub disc jockey to City Council representative to mayor of the country’s fifth-largest city, his views on how to improve community policing, and his take on a possible Donald Trump vs. Hillary Clinton general election.
FOX News
FOXNews.com - Breaking news and video. Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.
FOX News

Search...

WebSite

mySSnews Login



User Menu